OS-033 A phase 2 open-label study to evaluate safety, tolerability, efficacy, and pharmacodynamics of JNJ-73763989, nucleos (t)ide analogs, and a low-dose PD-1 inhibitor in patients with chronic hepatitis B-Interim results of the OCTOPUS-1 study

Autor: Asselah, Tarik, Fung, Scott K., Akhan, Sila, Chuang, Wan-Long, Buti, Maria, Brunetto, Maurizia, Agarwal, Kosh, Diba, Camellia, Jerzorwski, John, Kakuda, Thomas, Nalpas, Catherine, Guinard-Azadian, Carine, Verbinnen, Thierry, Lathouwers, Erkki, De Creus, An, Lenz, Oliver, Biermer, Michael
Zdroj: In Journal of Hepatology June 2024 80 Supplement 1:S27-S28
Databáze: ScienceDirect
Externí odkaz: